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Oxa1p is a key component of the machinery for the insertion of membrane proteins in mitochondria, and in the yeast Saccharomyces
cerevisiae, the deletion of OXA1 impairs the biogenesis of the three respiratory complexes of dual genetic origin. Oxa1p is formed from three
domains located in the intermembrane space, the inner membrane and the mitochondrial matrix. We have isolated a high copy suppressor able
to partially compensate for the respiratory deficiency caused by a large deletion of the matrix domain. We show that the suppressor gene
corresponds to the nuclear transcriptional activator Hap4p which is known to regulate respiratory functions.
D 2005 Elsevier B.V. All rights reserved.Keywords: Mitochondria; Respiratory complexes; Saccharomyces cerevisiae; Cytochrome oxidase; Membrane insertion1. Introduction
The biogenesis of membrane oligomeric complexes of
the mitochondrial respiratory chain is an intricate process
that requires the co-assembly of mitochondrial and nuclear
encoded subunits and the participation of nuclear-encoded
factors that are not intrinsic components of the complex.
Most of these proteins are conserved through evolution and
several human neurodegenerative pathologies are due to
respiratory complex assembly defects.
Oxa1p is functionally conserved from bacteria to
eukaryotic organelles and is a key component of the
insertion machinery of membrane subunits. In the yeast
Saccharomyces cerevisiae, the deletion of OXA1 impairs the
biogenesis of the three respiratory complexes of dual genetic0378-1119/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.gene.2005.03.016
Abbreviations: PCR, polymerase chain reaction; ORF, open reading
frame; TM, trans-membrane domain.
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are rapidly degraded (Bonnefoy et al., 1994; Altamura et al.,
1996; Lemaire et al., 2000). Moreover, Oxa1p seems
essential for the translocation of the hydrophilic domain of
the complex IV subunit, Cox2p (He and Fox, 1997; Hell et
al., 1997; Herrmann and Bonnefoy, 2004). Oxa1p interacts
with nascent mitochondrial polypeptides (Hell et al., 2001)
and its C-terminal tail located in the mitochondrial matrix
binds the mitochondrial ribosome. This interaction has been
proposed to mediate the co-translational insertion of
mitochondrially encoded subunits (Szyrach et al., 2003;
Jia et al., 2003). Oxa1p show an N-out C-in topology
(Herrmann et al., 1997) with three domains located in the
intermembrane space, the inner membrane and the matrix.
In order to clarify the precise role of these domains, we have
constructed point and deletion mutants (Lemaire et al.,
2004) and we have undertaken a systematic search for
suppressors able to compensate for the respiratory defi-
ciency due to various oxa1 mutations.
We have already isolated two classes of extragenic
suppressors able to compensate the respiratory deficiency
of oxa1 mutants. First, suppressor mutations located in the5) 53 – 57
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III, Cyt1p and Qcr9p, are able to compensate for the absence
of Oxa1p (Doxa1). We have proposed that these mutated
TM domains of Cyt1p or Qcr9p could interact with the TM
domains of other respiratory complex subunits leading to an
insertion process independent of Oxa1p (Hamel et al., 1998;
Saint-Georges et al., 2001). Second, the high copy
suppressor gene, OMS1, encoding a methyl-transferase like
protein, is specific for some oxa1 alleles. The over-
expression of OMS1 increases the steady-state level of
Oxa1p and thus facilitates the membrane insertion of
respiratory subunits. This stabilization of Oxa1p could
result from modifications of Oxa1p residues or of phos-
pholipids (Lemaire et al., 2004). Thus, the suppression
mechanisms are both acting at the assembly level but appear
completely different in both cases.
In this paper, we describe the characterization of a new
high copy suppressor of an oxa1 mutation. We show that the
suppressor gene corresponds to the transcriptional activator
Hap4p which is known to regulate respiratory functions.2. Materials and methods
2.1. Strains, media and genetic techniques
All strains were derived from the W303 nuclear back-
ground MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112
can1-100. The oxa1 mutants were described in Lemaire et
al. (2004). The Dafg3 strain (afg3::HIS3) and the Dhap4
(hap4::G418) strain are from A. Tzagoloff and B. Guiard.
Yeast genetic methods and media used for S. cerevisiae have
been described in Dujardin et al. (1980). Glucose or
galactose were used as fermentable carbon sources and
glycerol as a respiratory carbon source. Yeast cells were
transformed by the lithium acetate procedure of Schiestl and
Gietz (1989) for library screening.
2.2. High copy suppressor isolation
The oxa1 mutant was transformed with a high copy
library constructed by F. Lacroute into the URA3 2A vector
pFL44L. [Ura+] clones were selected and replica-plated onto
glycerol medium at 36 -C. Total yeast genomic DNA was
extracted from fast or slow-growing co-segregating [Gly+]
clones and used to transform Escherichia coli cells to
recover the plasmids. Molecular analysis by restriction
enzymes and sequencing identified the chromosomal frag-
ments present in each plasmid.
2.3. Epitope tagging of Oxa1p
Oxa1p was tagged at its C-terminus with a six histidine
epitope using the Saccharomyces pombe HIS5 marker gene
as described in Longtine et al. (1998). The PCR fragment was
used to transform the starting strain to histidine prototrophy inorder to fuse the tag to the end of the OXA1 ORF in the yeast
genome. Correct integration was confirmed by PCR ampli-
fication and sequencing. The strain CWOXA expressing the
tagged protein is respiratory competent at 28 -C and 36 -C
showing that the tagged protein is fully functional.
2.4. Isolation of mitochondria, Western blotting
Mitochondria were purified following the differential
centrifugation procedures after digestion of cell walls by
Zymoliase-100T (Kermorgant et al., 1997). The mitochon-
drial protein concentration was determined using the Bio-
Rad assay. Mitochondrial proteins were separated on 12%
acrylamide gels and blotted onto nitrocellulose membranes.
Western blots were probed with various antibodies using the
standard chemi-luminescence method.3. Results and discussion
3.1. Over-expression of HAP4 compensates for the respi-
ratory deficiency of oxa1-DL1-K332* mutant
In the search for genetic interactions involving the OXA1
gene, we decided to search for high copy suppressor genes
able to alleviate the respiratory defect of oxa1 mutants. In
oxa1-DL1-K332*, the Oxa1p variant presents a large deletion
of the first loop (L1) and a premature stop codon at position
332 in the C-terminal tail; both these domains protrude into
the matrix. This mutant presents a tight respiratory deficiency
associated to a strong defect in complex IV assembly and
activity and a much weaker effect on complexes III and V
(Lemaire et al., 2004). Three plasmids carrying overlapping
fragments of chromosome XI (see Fig. 1A and B) were able
to compensate for the respiratory deficiency of the mutation
oxa1-DL1-K332*. By subcloning the larger 7-kb insert of
YEpSu1 (YEPSu1A and YEPSu1B), we demonstrated that
the HAP4 gene was responsible for the suppression.
Surprisingly, the 4-kb fragment present in YEpSu8 and
YEpSu22 exhibits a truncated HAP4 gene encoding a 471-
residue protein lacking the last 83 amino acids when
compared to the full-length Hap4p. However, the over-
expression of this truncated gene (HAP4-S allele) is as active
in suppression as the complete HAP4 gene.
Hap4p is responsible for the transcriptional activation
capability of the Hap2/3/4/5 complex that positively
regulates many of the genes involved in respiratory
functions (Forsburg and Guarente, 1989). According to
Bourgarel et al. (1999) and Stebbins and Triezenberg
(2004), there is, in the C-terminal part of Hap4p, an
activation domain that extends from the positions 450 to
471. In order to determine if the last 83 amino acids were
required for the Hap4p activity, we have transformed the
Dhap4 strain with the plasmid carrying the truncatedHAP4-S
gene. As shown in Fig. 2, the HAP4-S gene is able to fully
complement the respiratory defect of the Dhap4 strain.
∆hap4
vector
HAP4-S
HAP4
glu              gly
Fig. 2. The truncated HAP4 gene fully complements the absence of Hap4p.
The Dhap4 mutant was transformed with the plasmids carrying the
truncated (YEpSu8, HAP4-S) and full-length HAP4 gene as well as with
the empty control vector. The respiratory growth was tested as in Fig. 1,
panel B.
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Fig. 1. The HAP4 gene is a high copy suppressor of the oxa1-DL1-K332*
mutant. (A) The thick grey bar represents the region of chromosome XI
carrying the suppressor gene. The arrows indicate the direction of
transcription of the different ORFs present in this region. The genomic
fragments inserted in the plasmids are indicated by thin straight lines.
YEpSu1, YEpSu8 and YepSu22 were obtained after transformation of the
oxa1 mutant by the high copy library in pFL44 (see Materials and
methods); YEpSu22 is identical to YEpSu8. YEpSu1A and YEpSu1B were
obtained by sub-cloning YEpSu1 using the sites BamH1 and Pml1. The
mutant cells were transformed with these different plasmids and the
respiratory growth of transformants was tested as described in panel (B).+
respiratory growth;  no growth. (B) The oxa1-DL1-K332* mutant was
transformed with six plasmids : YEp30 carrying the OXA1 gene, the empty
control vector pFL44, the YEpSu1 and YEpSu8 plasmids expressing the
truncated (HAP4-S) and full-length HAP4 gene, YEpPH66 carrying the
CYT1-1 genetic suppressor (Hamel et al., 1998) and pNB212 carrying the
high copy suppressor OMS1 (Lemaire et al., 2004), respectively. The cells
were patched on minimal glucose medium lacking uracil (Glu), replica-
plated on non-fermentable substrate (Gly) and incubated at 28 -C for 10
days. The respiratory competent papillae correspond to genetic revertants.
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for both suppression and complementation.
3.2. Specificity of the suppression by over-expression of
HAP4
We have compared the suppression efficiency of HAP4
to the previously isolated suppressors (see Fig. 1B). The
suppressor mutation CYT1-1 is able to compensate for the
total absence of Oxa1p while the over-expression of OMS1
does not compensate for the absence of Oxa1p but
suppresses partial oxa1 defects (Lemaire et al., 2004). The
over-expression of HAP4 is able to partially restore the
growth of the oxa1-DL1-K332* mutant on respiratorysubstrates but cannot compensate for the respiratory defects
observed in the null allele, Doxa1 (not shown). We have
also tested the missense mutation oxa1-WW>AA which is
clearly suppressed by CYT1-1 and OMS1. In this mutant, a
pair of tryptophan residues (positions 128–129) in or close
to the first trans-membrane segment TM1, are replaced by a
pair of alanine residues. The mutant oxa1-WW>AA exhibits
a slight growth delay on respiratory medium at 28 -C and a
tight respiratory deficiency at 36 -C associated to a strong
reduction in complex IV activity (Lemaire et al., 2004). The
over-expression of HAP4 suppresses the growth delay at 28
-C but does not restore the respiratory capacity at 36 -C,
even after extended incubation. Interestingly, the suppres-
sion of oxa1-DL1-K332* by HAP4 is also much weaker at
36 -C than at 28 -C (not shown). Thus, HAP4 is a high copy
suppressor of partial oxa1 defects and this suppression
appears more efficient at 28 -C. As Oxa1p is involved in the
insertion of the membrane subunits of respiratory com-
plexes, this effect of temperature could be due to temper-
ature-dependent modifications of the mitochondrial
membrane or protein folding.
3.3. HAP4 over-expression strongly increases the steady-
state level of Cox2p in the oxa1-DL1-K332* mutant
Lascaris et al. (2003) have shown that cells over-
expressing HAP4 up-regulate genes involved in mitochon-
drial biogenesis and activity. In particular, in a genome-wide
expression experiment, OXA1 mRNA appears induced
about twofold by HAP4 over-expression even though the
OXA1 promoter does not contain the consensus regulatory
sequence of the Hap2/3/4 complex. As we have previously
shown that increasing the level of mutated Oxa1p can
compensate for its own defect (Lemaire et al., 2004), HAP4
over-expression could be also responsible for an increase in
the steady-state level of Oxa1p. In order to test this
hypothesis, we have used a strain with a tagged form of
Oxa1p (see Materials and methods) and transformed this
strain with the high copy plasmid carrying the HAP4 gene
(YEpSu1) or the empty plasmid (pFL44L) and purified
vector    HAP4 OXA1
oxa1-∆L1-K332*
Cox2p
Atp4p
Arg8p
Fig. 4. Effect of HAP4 over-expression on the steady-state level of
respiratory complex subunits in the oxa1-DL1-K332* mutant. The oxa1-
DL1-K332* cells transformed with the empty control vector, the YEpSu1 or
YEp30 plasmids over-expressing HAP4 or OXA1, respectively, were grown
in minimal galactose medium for selecting the plasmid and mitochondria
were purified. Mitochondrial proteins (80 Ag) were analyzed by Western
blotting (12% acrylamide gel) using the anti-Cox2p (Molecular Probes), the
anti-Atp4p (J. Velours), anti-Arg8p (T.D. Fox) antibodies.
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3A, we were not able to detect, in the strain over-expressing
HAP4, any significant increase in the state-level of Oxa1p
as compared to Arg8p. Arg8p is a mitochondrial protein not
involved in respiratory function and is not induced by HAP4
over-expression according to Lascaris et al. (2003). In
parallel, we have also transformed a mutant lacking the
mitochondrial matrix protease Afg3p, with the plasmids
carrying either HAP4, OXA1 or OMS1. Indeed, it is known
that over-expression of OXA1 can restore growth of the
Dafg3 mutant on respiratory substrates (Rep et al., 1996;
Lemaire et al., 2004). As shown in Fig. 3B, the Dafg3
mutant is not suppressed by the over-expression of HAP4
while over-expression of OXA1 or OMS1 which increases
the Oxa1p level (Lemaire et al., 2004) clearly restores
respiratory growth under the same conditions. Altogether,
these experiments suggest that the suppression via HAP4 is
not due to an increased steady-state level of Oxa1p.
Hap4p positively regulates the expression of several
genes involved in mitochondrial respiratory functions
(Forsburg and Guarente, 1989). Interestingly enough,
Northern analyses have shown that the over-expression of∆afg3
glu gly
HAP4
OXA1
OMS1
vector
Oxa1p-6his
HAP4 Vector
OXA1-6his
Arg8p
A
B
Fig. 3. HAP4 over-expression does not lead to a significant increase in
Oxa1p accumulation. (A) The CWOXA strain expressing a histidine tagged
form of Oxa1p (see Materials and methods) was transformed with the
YEpSu1 plasmid over-expressing HAP4 and the empty vector. Mitochon-
dria were purified from transformants grown in minimal galactose medium
for plasmid selection. Mitochondrial proteins (80 Ag) were analyzed by
Western blotting (12% acrylamide gel) using the anti-his (Tetrahis,
Quiagen) and the anti-Arg8 (T.D. Fox) antibodies. B) The Dafg3 mutant
was transformed with high copy plasmids carrying the OXA1, HAP4 or
OMS1 genes or with the empty vector and the respiratory growth was tested
as in panel B of Fig. 1.HAP4 significantly increases the steady-state level of COX2
mRNA (Lascaris et al., 2003). The oxa1-DL1-K332* mutant
exhibits a pleiotropic defect in respiratory complex assem-
bly and activity. In particular, the assembly of complex IV
and the steady-state level of Cox2p are strongly decreased
(Lemaire et al., 2004). Thus, the HAP4 effect on COX2
could be responsible for the suppression effect. We have
analysed the level of Cox2p in the oxa1-DL1-K332* mutant
transformed either with the high copy plasmid carrying the
HAP4 or the OXA1 gene. As shown in Fig. 4, the steady-
state level of Cox2p is very strongly increased by HAP4
over-expression in the oxa1-DL1-K332* mutant as com-
pared to the effect on the level of Arg8p. The steady-state
level of Atp4p is also slightly but reproducibly increased
(150%) by HAP4 over-expression.4. Conclusion
Whilst it is clear that the over-expression of a wild-type or
truncatedHAP4 gene is able to suppress the respiratory defect
of the oxa1-DL1-K332* mutant but does not compensate for
the absence of Oxa1p, the mechanism of this suppression
remains to be elucidated. The over-expression of HAP4 does
not seem to increase the steady-state level of Oxa1p but leads
to a strong increase in the level of Cox2p in the oxa1-DL1-
K332 mutant. This increase could explain the restoration of
respiratory functions as a reduction in complex IV assembly
and activity is the principal defect in the oxa1-DL1-K332*
mutant. As Cox2p is encoded in the mitochondrial genome, it
is probable that the effect of Hap4p is indirect. The increase in
the level of Cox2pmay be sufficient to explain the suppressor
effect; alternatively, the suppression may be due to a
combination of the increase of Cox2p and an increase in
O. Hlavacek et al. / Gene 354 (2005) 53–57 57the level of other mitochondrial proteins whose transcription
is controlled by Hap4p.
This suppression clearly differs from those previously
reported for the CYT1-1 and OMS1 suppressors that act at a
post-translational level of respiratory complex biogenesis.
Tight interactions exist between the synthesis and assembly
of respiratory complex subunits in mitochondria and are
essential for the biogenesis of mitochondrial respiratory
complexes. They are mediated through membrane-bound
translational activators (Sanchirico et al., 1998) and the
matrix C-terminal part of Oxa1p that was shown to interact
with ribosomes (Szyrach et al., 2003; Jia et al., 2003). Over-
expression of HAP4 suppresses the oxa1-DL1-K332*
mutant that exhibits a large deletion of the matrix domain
of Oxa1p. Thus, it is tempting to propose that the increase in
the expression of respiratory subunits compensate for the
defect in co-translational membrane insertion of these
subunits due to the oxa1 mutation.Acknowledgments
We thank F. Lacroute for the gift of the pFL44L genomic
library, A. Tzagoloff and B. Guiard for the Dafg3 and
Dhap4 strains, T.D. Fox and J. Velours for antibodies. We
thank N. Bonnefoy and C.J. Herbert for helpful discussions
and critical reading of the paper. O. Hlavacek was supported
by a grant from NATO Science Fellowship Program. This
work was supported by a research grant from the
‘‘Association Franc¸aise contre les Myopathies.’’References
Altamura, N., Capitanio, N., Bonnefoy, N., Papa, S., Dujardin, G., 1996.
The Saccharomyces cerevisiae OXA1 gene is required for the correct
assembly of cytochrome c oxidase and oligomycin-sensitive ATP
synthase. FEBS Lett. 382, 111–115.
Bonnefoy, N., Chalvet, F., Hamel, P., Slonimski, P.P., Dujardin, G., 1994.
OXA1, a Saccharomyces cerevisiae nuclear gene whose sequence is
conserved from prokaryotes to eukaryotes controls cytochrome oxidase
biogenesis. J. Mol. Biol. 239, 201–212.
Bourgarel, D., Nguyen, C., Bolotin-Fukuhara, M., 1999. HAP4, the
glucose-repressed regulated subunit of the HAP transcriptional complex
involved in the fermentation-respiration shift, has a functional homo-
logue in the respiratory yeast Kluyveromyces lactis. Mol. Microbiol. 31,
1205–1215.
Dujardin, G., Pajot, P., Groudinsky, O., Slonimski, P.P., 1980. Long range
control circuits within mitochondria and between nucleus and mito-
chondria: I. Methodology and phenomenology. Mol. Gen. Genet. 179,
469–472.
Forsburg, S.L., Guarente, L., 1989. Identification and characterization of
HAP4: a third component of the CCAAT-bound HAP2/HAP3 hetero-
mer. Genes Dev. 3, 1166–1178.
Hamel, P., Lemaire, C., Bonnefoy, N., Brivet-Chevillotte, P., Dujardin, G.,
1998. Mutations in the membrane anchor of yeast cytochrome c1compensate for the absence of Oxa1p and generate carbonate-
extractable forms of cytochrome c1. Genetics 150, 601–611.
He, S., Fox, T.D., 1997. Membrane translocation of mitochondrially
coded Cox2p: distinct requirements for export of N and C termini
and dependence on the conserved protein Oxa1p. Mol. Biol. Cell 8,
1449–1460.
Hell, K., Herrman, J., Pratje, E., Neupert, W., Stuart, R.A., 1997. Oxa1p
mediates the export of the N- and C- termini of pCoxII from the
mitochondrial matrix to the intermembrane space. FEBS Lett. 418,
367–370.
Hell, K., Neupert, W., Stuart, R.A., 2001. Oxa1p acts as a general
membrane insertion machinery for proteins encoded by mitochondrial
DNA. EMBO J. 20, 1281–1288.
Herrmann, J.M., Bonnefoy, N., 2004. Protein export across the inner
membrane of mitochondria: The nature of translocated domains
determines the dependence on the Oxa1 translocase. J. Biol. Chem.
279, 2507–2512.
Herrmann, J.M., Neupert, W., Stuart, R.A., 1997. Insertion into the
mitochondrial inner membrane of a polytopic protein, the nuclear-
encoded Oxa1p. EMBO J. 16, 2217–2226.
Jia, L., Dienhart, M., Schramp, M., McCauley, M., Hell, K., Stuart, R.A.,
2003. Yeast Oxa1 interacts with mitochondrial ribosomes: the impor-
tance of the C-terminal region of Oxa1. EMBO J. 22, 6438–6447.
Kermorgant, M., Bonnefoy, N., Dujardin, G., 1997. Oxa1p, which is
required for cytochrome c oxidase and ATP synthase complex
formation, is embedded in the mitochondrial inner membrane. Curr.
Genet. 31, 302–307.
Lascaris, R., et al., 2003. Hap4p overexpression in glucose-grown
Saccharomyces cerevisiae induces cells to enter a novel metabolic
state. Genome Biol. 4, R3.
Lemaire, C., Hamel, P., Velours, J., Dujardin, G., 2000. Absence of the
mitochondrial AAA protease Yme1p restores F0-ATPase subunit
accumulation in an oxa1 deletion mutant of Saccharomyces cerevisiae.
J. Biol. Chem. 275, 23471–23475.
Lemaire, C., Guibet-Grandmougin, F., Angles, D., Dujardin, G., Bonnefoy,
N., 2004. A yeast mitochondrial membrane methyltransferase-like
protein can compensate for oxa1 mutations. J. Biol. Chem. 279,
44464–44472.
Longtine, M.S., et al., 1998. Additional modules for versatile and
economical PCR-based gene deletion and modification in Saccharo-
myces cerevisiae. Yeast 14, 953–961.
Rep, M., Nooy, J., Guelin, E., Grivell, L.A., 1996. Three genes for
mitochondrial proteins suppress null-mutations in both Afg3 and Rca1
when over-expressed. Curr. Genet. 30, 206–211.
Saint-Georges, Y., Hamel, P., Lemaire, C., Dujardin, G., 2001. Role of
positively charged transmembrane segments in the insertion and
assembly of mitochondrial inner-membrane proteins. Proc. Natl. Acad.
Sci. U. S. A. 98, 13809–13814.
Sanchirico, M.E., Fox, T.D., Mason, T.L., 1998. Accumulation of
mitochondrially synthesized Saccharomyces cerevisiae Cox2p and
Cox3p depends on targeting information in untranslated portions of
their mRNAs. EMBO J. 17, 5796–5804.
Schiestl, R., Gietz, R., 1989. High efficiency transformation of intact yeast
cells using single stranded nucleic acids as a carrier. Curr. Genet. 16,
339–346.
Stebbins, J., Triezenberg, S., 2004. Identification, mutational analysis, and
coactivator requirements of two distinct transcriptional activation
domains of the Saccharomyces cerevisiae Hap4 protein. Eukaryot. Cell
3, 339–347.
Szyrach, G., Ott, M., Bonnefoy, N., Neupert, W., Herrmann, J.M., 2003.
Ribosome binding to the Oxa1 complex facilitates co-translational
protein insertion in mitochondria. EMBO J. 22, 6448–6457.
